Wasatch Advisors Inc Neuronetics, Inc. Transaction History

Wasatch Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$4.03 - $9.22 $2.02 Million - $4.63 Million	-502,319 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.31 - $13.03 $1.01 Million - $1.59 Million	121,921 Added 32.05%	502,319 $4.17 Million
Q2 2019 Aug 07, 2019	BUY	$9.0 - $17.2 $597,996 - $1.14 Million	66,444 Added 21.16%	380,398 $0
Q1 2019 May 08, 2019	BUY	$13.6 - $19.58 $812,464 - $1.17 Million	59,740 Added 23.5%	313,954 $0
Q4 2018 Feb 14, 2019	BUY	$16.0 - $31.84 $2.44 Million - $4.86 Million	152,714 Added 150.46%	254,214 $4.92 Million
Q2 2018 Aug 02, 2018	BUY	$26.61 - $27.78 $2.7 Million - $2.82 Million	101,500 New	101,500 $0

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $21.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Wasatch Advisors Inc with notifications on news.